Combined use of dopamine and serotonin agonists in the treatment

Details Combined use of dopamine and serotonin agonists in the treatment Combined use of dopamine and serotonin agonists in the treatment

1994-11-01

1996-03-26

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514885, A61K 31135

Patent

active

055020801

ABSTRACT:
Allergic conditions are treated and allergic symptoms mitigated or resolved by the administration of a dopamine agonist such as fenfluramine and/or 5-hydroxytriptophan administered concurrently or in association with a serotonin agonist such as phentermine.

REFERENCES:
patent: 4255439 (1981-03-01), Cooper
patent: 4895845 (1990-01-01), Seed
McMurray et al, Medline Abstract No. 94343376, 1994.
Bravo et al, Medline Abstract No. 92309257, 1992.
Riskind et al, Medline Abstract No. 91315169, 1991.
J. of Substance Abuse Treatment, vol. 11, No. 3, pp. 273-275, Oct. 1994, Letter to the Editor.
Maryland Medical Journal, Feb. 1993, Hitzig, "Combined dopamaine and serotonin agonists: A synergistic approach to alcoholism and other addictive behaviors".

Affiliated with

Also associated with

Rating

Combined use of dopamine and serotonin agonists in the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined use of dopamine and serotonin agonists in the treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of dopamine and serotonin agonists in the treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-915955